Article
Published 21 Jul 2025
The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119
McMillan LLP
Your search returned 3,285 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 17 Jul 2025
Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness
Aird & Berlis LLP
Article
Published 15 Jul 2025
2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law
Smart & Biggar
Article
Published 11 Jul 2025
Important New Procedural Guidelines From The PMPRB
Aird & McBurney LP
Article
Published 10 Jul 2025
Final Guidelines From Canada's PMPRB: The New Era Begins
Torys LLP
Article
Published 10 Jul 2025
The Trademark Four(Mula): Enforcement And Risk Mitigation
Osler, Hoskin & Harcourt LLP
Article
Published 10 Jul 2025
Q&A On Managing Intergenerational Growth In Canadian Agribusiness
Bennett Jones LLP
Article
Published 9 Jul 2025
July 2025 Rosen Sunshine Newsletter
Rosen Sunshine LLP
Article
Published 9 Jul 2025
Finalized PMPRB Guidelines Published
Smart & Biggar
Article
Published 9 Jul 2025
At Long Last: The New PMPRB Guidelines Are Here
Fasken
Article
Published 8 Jul 2025
CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary
Smart & Biggar
Article
Published 7 Jul 2025
North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims
Lenczner Slaght LLP
Article
Published 7 Jul 2025
CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025
Fasken
Article
Published 7 Jul 2025
Health Canada's New Draft Guidance For Biosimilar Biologic Drugs
Fasken
Article
Published 1 Jul 2025
Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training
Smart & Biggar
Article
Published 1 Jul 2025
Pharma, National Security And Tariffs: Where Do We Go From Here?
Borden Ladner Gervais LLP
Article
Published 30 Jun 2025
Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access
Torys LLP
Article
Published 30 Jun 2025
Update On Biosimilars In Canada – June 2025
Smart & Biggar
Article
Published 27 Jun 2025
Travel Insurance And Alcohol: What Every Canadian Needs To Know
Wallace Smith LLP
Article
Published 26 Jun 2025
La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires
Fasken (French)